Not available
Quote | BioSyent Inc. (OTCMKTS:BIOYF)
Last: | $7.62 |
---|---|
Change Percent: | 1.58% |
Open: | $7.76 |
Close: | $7.5018 |
High: | $7.76 |
Low: | $7.62 |
Volume: | 250 |
Last Trade Date Time: | 06/26/2024 03:00:00 am |
News | BioSyent Inc. (OTCMKTS:BIOYF)
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a Euro...
2024-05-17 01:38:24 ET More on BioSyent Historical earnings data for BioSyent Dividend scorecard for BioSyent Financial information for BioSyent Read the full article on Seeking Alpha For further details see: BioSyent GAAP EPS of C$0.15, revenue o...
Message Board Posts | BioSyent Inc. (OTCMKTS:BIOYF)
Subject | By | Source | When |
---|---|---|---|
BioSyent Launches Combogesic, First-Ever Acetaminophen + Ibuprofen Combination | HomerRomer | investorshub | 12/22/2020 10:16:52 PM |
Anyone still here? | Twinsoul | investorshub | 09/20/2018 9:46:57 PM |
BioSyent Releases Results for Third Quarter and First | Trent Blair | investorshub | 11/19/2015 8:04:59 AM |
$BIOYF - BioSyent Releases First Six Months 2015 | JustGoLong | investorshub | 08/12/2015 2:01:36 PM |
Anyone still here? | ronpopeil | investorshub | 05/27/2015 8:18:59 PM |
News, Short Squeeze, Breakout and More Instantly...
MISSISSAUGA, Ontario, June 12, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its wholly-owned subsidiary, BioSyent Pharma Inc. (“BioSyent Pharma”), has entered into an agreement with a Euro...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) released today its financial results for the three months (Q1) ended March 31, 2024. Key highlights include: Return on Equity for TTM March 31, 2024 was 21% as compared to 15% ...
MISSISSAUGA, Ontario, May 16, 2024 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, “the Company”, TSX Venture: RX) is pleased to announce that its Board of Directors has declared a quarterly dividend of $0.045 per common share, payable in Canadian Dollars on June 15, 20...